ArticleGalen medical journal2025
Evaluation of Gene Expression of Mirna 21 and 98 Effect on Liver Functions in Fibrotic Patients : Evaluation of Gene Expression of Some miRNAs and Liver Functions in Fibrotic Patients.
Article in Galen medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Liver fibrosis is one of concerning outcomes of hepatitis with a complex interaction of different pathological processes including the epigenetics. MicroRNAs (miRNA) like miRNA 21 and 98 are recently being emphasized in era of epigenetics of liver diseases. The current study aims to evaluate liver function and the role of miRNA 21 and 98 in the occurrence of liver fibrosis. Materials and Methods: This was a case-control study comparing liver fibrosis patients with healthy adults with intact liver function as the control group. Laboratory and clinical tests were performed to evaluate liver function, and the diagnosis of viral hepatitis was confirmed using ELISA kits. Reverse transcription polymerase chain reaction (RT-PCR) was used to analyze the expression levels of microRNA 21 and 98, following the extraction of RNA from the samples. Results: Our study included 44 cases and 44 controls. Results revealed significant differences in demographic, clinical, and biochemical properties. Cases had higher mean BMI (34.36 ± 9.14 kg/m2, P=0.0486), higher levels of TSB, ALP, ALT, AST, and CRP, and lower albumin levels (P 0.05 for all). Gene expression analysis showed higher miRNA 21 (1.14, P 0.05) and lower miRNA 98 (1.68, P 0.05) in cases compared to controls. Among case group, females had higher expression of miRNA 21 (1.082 ± 0.23) and miRNA 98 (1.895 ± 0.41) compared to males (P0.05). Additionally, cases infected with HBV had higher expression of miRNA 21 (1.201 ± 0.31) and miRNA 98 (2.985 ± 0.56) compared to those infected with HCV (P0.05). Conclusion: In conclusion, miRNA 21 and miRNA 98 might be associated with liver fibrosis; while the exact pathophysiological explanation reminds unclear.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.